Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

ICF-based interdisciplinary case management for adults with intellectual disability

Official title: Application of the International Classification of Functioning, Disability, and Health (ICF) on Interdisciplinary Case Management for Healthcare Service Delivery for Individuals With Disabilities

Run by The Hong Kong Polytechnic University · NCT07813806 · Data updated 2026-11-12

This study tests whether an ICF-based interdisciplinary case management approach can improve functioning, participation, and quality of life for adults with mild to moderate intellectual disability receiving community rehabilitation services.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment120 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedJune 14, 2027
Study endsJune 14, 2027
Registry record updatedSeptember 10, 2026
Trial IDNCT07813806 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 years with mild (IQ 50–69) to moderate (IQ 35–49) intellectual disability who can communicate in Cantonese or English.

Probably not a fit

Participants with severe medical or psychiatric conditions or those unable to participate in the intervention may receive little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll 120 adults aged 18–60 with mild to moderate intellectual disability and randomly assign them to an ICF-based interdisciplinary case management group or to conventional care management. The intervention uses coordinated assessments, goal-setting, intervention planning, and outcome evaluation by an interdisciplinary team, guided by the Rehab-Cycle framework and the ICF. The control group continues to receive standard community rehabilitation services. Outcomes will be measured before and after the intervention to see changes in functioning, activity participation, and quality of life.

Why it matters

Potential benefit: If successful, participants may experience better daily functioning and greater participation in community life.

How similar studies have gone: Previous work has explored ICF-based approaches in rehabilitation, but effectiveness in community-based services for intellectual disability requires evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. between the age of 18 and 60 years old,
2. intellectual disability with mild grade (IQ 50-69) or moderate grade (IQ 35-49) as confirmed by medical doctors,
3. ability to communicate verbally in Cantonese or English.

Exclusion Criteria:

1. acute and unstable medical conditions (such as seizures),
2. Current or recent diagnosis of severe psychiatric disorders (e.g., active psychosis, major depressive episode within the past 12 months, or other conditions that significantly impair participation)

Their caregivers will provide proxy consent if the participants with intellectual disability were unable to give the informed consent.

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Sam Chi Chung Chan — The Hong Kong Polytechnic University
  • Study coordinator: Sam Chi Chung Chan, PhD
  • Email: samcc.chan@polyu.edu.hk
  • Phone: 27664310

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.